Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, January 17, 2023
Charles River Laboratories International, Inc. announced the launch of their new CliniPrimeTM suite of Good Manufacturing Practice (GMP)-compliant cellular starting materials.
read more
Thursday, December 05, 2024
Charles River Laboratories International, Inc. announced the launch of the Charles River Incubator Program (CIP), specializing in supporting early-stage biotechnology companies in the discovery, development and phase-appropriate manufacturing of ...
read more
Thursday, October 17, 2024
Charles River Laboratories International, Inc. announced the launch of the Retrogenix® Non-Human Protein Library. The non-human protein library helps biopharmaceutical clients assess off-target binding to a non-human proteome to de-risk in vivo ...
read more
Charles River Laboratories announced several key expansions to its global Biologics Testing Solutions infrastructure to support the characterization, development, and release of biologics and biosimilars.
read more
Monday, September 25, 2023
Charles River Laboratories International, Inc. announced the opening of another RightSourceSM facility, and first in the United Kingdom, which will provide services to the Stevenage advanced therapies biocluster.
read more
Wednesday, January 20, 2021
Charles River Laboratories has entered into a strategic partnership with JADE, a provider of end-to-end quality management services for the biopharmaceutical industry.
read more
Wednesday, February 14, 2018
Charles River Laboratories has entered into a definitive agreement to acquire MPI Research for approximately $800 million in cash, subject to customary closing adjustments.
read more
Thursday, October 21, 2021
Charles River Laboratories announced the expansion of its Charles River Accelerator and Development Lab (CRADL™) on Binney Street in Cambridge, Massachusetts, and the addition of a second Cambridge location on Bent Street. CRADL provides flexible, ...
read more
Charles River Laboratories announced the planned opening of the Charles River Accelerator and Development Lab (CRADL™) in South San Francisco in early 2020.
read more
Charles River Laboratories International, Inc. announced a Good Manufacturing Practice- (GMP) plasmid DNA contract development and manufacturing organization (CDMO) agreement. Ship of Theseus will leverage Charles River’s premier expertise to ...
read more
Charles River Laboratories International, Inc. announced a contract development and manufacturing organization (CDMO) agreement to produce Good Manufacturing Practice- (GMP) plasmid DNA.
read more
Wednesday, January 16, 2019
Charles River Laboratories has collaborated with Atomwise on integrated and artificial intelligence (AI)-driven drug discovery.
read more
Charles River Laboratories has entered into an exclusive partnership with Fios Genomics, a provider of bioinformatics data analysis services.
read more
Friday, November 20, 2020
PathoQuest and Charles River has established a U.S. subsidiary, PathoQuest and will construct a next generation sequencing-based testing laboratory at Charles River’s site in Wayne, PA.
read more
Charles River Laboratories and PathoQuest announced an expansion of their strategic partnership agreement to provide next-generation sequencing (NGS) services to the biologics industry.
read more